Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A panelist discusses how the most effective therapy for squamous cell anal carcinoma is prevention through human ...

A panelist discusses how the POD1UM-303 randomized phase 3 trial demonstrated that adding retifanlimab (a PD-1 inhibitor) to ...

Results come after positive results from a trial among people with idiopathic pulmomary disease.

An investigational oral targeted therapy, zipalertinib (CLN-081), demonstrated meaningful tumor responses and a manageable ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...

In a conversation with Managed Healthcare Executive, Michael Abrams, M.A., managing partner at Numerof & Associates, painted ...

The healthcare provisions include Medicaid work requirements and a broadening of the exemption to Medicare drug price negotiation ...

In an opinion article, investigators argue that gene therapies may not achieve their full potential if the innate inflammation in Duchenne muscular dystrophy is not effectively managed.

While the impact of Medicaid changes on employer-sponsored insurance remains to be seen, competition between providers is a ...

Health plans must embrace real-time member awareness, timely clinical context and actionable insights to realize the benefits ...